Use of a neurotoxic component of a Clostridium botulinum toxin complex to reduce or prevent side effects

Details for Australian Patent Application No. 2008340713 (hide)

Owner Merz Pharma GmbH & Co. KGaA

Inventors Marx, Matthias; Haunold, Erich

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008340713

PCT Pub. Number WO2009/080272

Priority 61/009,010 21.12.07 US; 07024961.0 21.12.07 EP

Filing date 17 December 2008

Wipo publication date 2 July 2009

International Classifications

A61K 8/64 (2006.01) Cosmetics or similar toilet preparations

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61Q 19/08 (2006.01) Preparations for care of the skin - Anti-ageing preparations

Event Publications

15 July 2010 PCT application entered the National Phase

  PCT publication WO2009/080272 Priority application(s): WO2009/080272

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008340715-Container having multiple connected packs

2008340706-Catheter assembly with a folded urine collection bag